Micro
ribonucleic acids (
miRNAs) are small endogenous noncoding RNAs molecules that regulate gene expression post-transcriptionally. A single
miRNA is able to target hundreds of specific
messenger RNA (mRNAs) by binding to the 3'-untranslated regions.
miRNAs regulate different biological processes such as cell proliferation, differentiation and apoptosis. Altered
miRNA expression is certainly related to the development of the most common human diseases, including
tumors.
Osteosarcoma (OS),
Ewing's Sarcoma (ES), and
Chondrosarcoma (CS) are the most common primary bone
tumors which affect mainly children and adolescents. A significant dysregulation of
miRNA expression, in particular of mir-34, mir-21, mir-106, mir-143, and miR-100, has been revealed in OS, ES and CS. In this context,
miRNAs can act as either tumor suppressor genes or oncogenes, contributing to the initiation and progression of bone
tumors. The in-depth study of these small molecules can thus help to better understand their biological functions in bone
tumors. Therefore, this review aims to examine the potential role of
miRNAs in bone
tumors, especially OS, ES and CS, and to suggest their possible use as potential therapeutic targets for the treatment of bone
tumors and as
biomarkers for early diagnosis.